CollPlant Q2 Results Reveal Cash Burn and LightSolver Integration Progress
CLGN sits 43% above its 52-week low of $2.637.
Summary
CollPlant reported Q2 2026 financials, with revenue and a GAAP net loss of $2.7 million that will be scrutinized against its $7.1M market cap. The company also provided a corporate update, likely detailing the LightSolver acquisition and the completed 1-for-10 reverse split. CollPlant amended the LightSolver purchase agreement to assume all vested and unvested Section 3(i) options, converting them into CollPlant options. Given the recent going concern warning and heavy insider buying, the cash position and burn rate are the key numbers. The reverse split took effect September 4, so all current prices are post-split. Traders will focus on whether the LightSolver deal is accretive or dilutive and whether the company has enough runway to reach commercialization.
Updated with an SEC 6-K filing · What changed
Updates
· SEC 6-K — CollPlant amended the LightSolver purchase agreement to assume all vested and unvested Section 3(i) options, converting them into CollPlant options, and reported Q2 GAAP net loss of $2.7 million.
At the time of this announcement, CLGN was trading at $3.78 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $7.1M. The 52-week trading range was $2.64 to $28.00. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: PR Newswire.